{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:18:15Z","timestamp":1792793895458,"version":"4.5.0"},"reference-count":136,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Lung transplant patients have the lowest long-term survival rates compared to other solid organ transplants. The complications after lung transplantation such as primary graft dysfunction (PGD) and ultimately chronic lung allograft dysfunction (CLAD) are the main reasons for this limited survival. In recent years, lung-specific autoantibodies that recognize non-HLA antigens have been hypothesized to contribute to graft injury and have been correlated with PGD, CLAD, and survival. Mounting evidence suggests that autoantibodies can develop during pulmonary disease progression before lung transplant, termed pre-existing autoantibodies, and may participate in allograft injury after transplantation. In this review, we summarize what is known about pulmonary disease autoantibodies, the relationship between pre-existing autoantibodies and lung transplantation, and potential mechanisms through which pre-existing autoantibodies contribute to graft injury and rejection.<\/jats:p>","DOI":"10.3389\/fimmu.2021.711102","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T03:01:07Z","timestamp":1628650867000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant"],"prefix":"10.3389","volume":"12","author":[{"given":"Alexander","family":"McQuiston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Emtiazjoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggi","family":"Angel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Machuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.07.85","article-title":"Outcomes After Lung Transplantation","volume":"9","author":"Thabut","year":"2017","journal-title":"J Thorac Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1586\/eci.12.7","article-title":"Autoimmunity in Chronic Obstructive Pulmonary Disease: Clinical and Experimental Evidence","volume":"8","author":"Kheradmand","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"B3","article-title":"Pulmonary Manifestations of Systemic Autoimmune Diseases","volume-title":"Maedica","author":"Cojocaru","year":"2011"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00012704","article-title":"The Impact of Smoking Cessation on Respiratory Symptoms, Lung Function, Airway Hyperresponsiveness and Inflammation","volume":"23","author":"Willemse","year":"2004","journal-title":"Eur Respir J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7382","article-title":"Oxidative Modifications in Tissue Pathology and Autoimmune Disease","volume":"29","author":"Yang","year":"2018","journal-title":"Antioxidants Redox Signal"},{"key":"B6","first-page":"1","article-title":"Oxidative Biomolecular Damage: A Possible Mechanism for Systemic Autoimmunity","volume":"13","author":"Rasheed","year":"2019","journal-title":"Int J Health Sci (Qassim)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.00066","article-title":"Autoantibodies in Chronic Obstructive Pulmonary Disease","volume":"9","author":"Wen","year":"2018","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201010-1727ED","article-title":"Autoimmunity in Idiopathic Pulmonary Fibrosis","volume":"183","author":"Feghali-Bostwick","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200701-014OC","article-title":"Autoantibodies in Patients With Chronic Obstructive Pulmonary Disease","volume":"177","author":"Feghali-Bostwick","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.17509460","article-title":"Lymphocyte Population and Apoptosis in the Lungs of Smokers and Their Relation to Emphysema","volume":"17","author":"Majo","year":"2001","journal-title":"Eur Respir J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/ijerph15051033","article-title":"Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review","volume":"15","author":"Strzelak","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.imlet.2019.08.007","article-title":"Autoantibodies in Chronic Obstructive Pulmonary Disease: A Systematic Review","volume":"214","author":"Byrne","year":"2019","journal-title":"Immunol Lett"},{"key":"B13","doi-asserted-by":"publisher","first-page":"102743","DOI":"10.1016\/j.autrev.2020.102743","article-title":"An Updated Advance of Autoantibodies in Autoimmune Diseases","volume":"20","author":"Xiao","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/COPD.S235903","article-title":"Serum Levels of Autoantibodies Against Extracellular Antigens and Neutrophil Granule Proteins Increase in Patients With COPD Compared to Non-COPD Smokers","volume":"15","author":"Ma","year":"2020","journal-title":"Int J COPD"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.01.006","article-title":"Natural Autoantibodies in the Physiology and Pathophysiology of the Immune System","volume":"41","author":"Avrameas","year":"2013","journal-title":"J Autoimmun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e60726","DOI":"10.1371\/journal.pone.0060726","article-title":"Natural IgG Autoantibodies Are Abundant and Ubiquitous in Human Sera, and Their Number Is Influenced By Age, Gender, and Disease","volume":"8","author":"Nagele","year":"2013","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1038\/489S15a","article-title":"Clues, Not Conclusions","volume":"489","author":"Duncan","year":"2012","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2020.19131","article-title":"Putative Functional Pathogenic Autoantibodies in Systemic Sclerosis","volume":"7","author":"Benfaremo","year":"2020","journal-title":"Eur J Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/art.24621","article-title":"RNA Helicase Encoded by Melanoma Differentiation-Associated Gene 5 Is a Major Autoantigen in Patients With Clinically Amyopathic Dermatomyositis: Association With Rapidly Progressive Interstitial Lung Disease","volume":"60","author":"Sato","year":"2009","journal-title":"Arthritis Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ajpath.2015.11.010","article-title":"Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies","volume":"186","author":"Allenbach","year":"2016","journal-title":"Am J Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/atm.2017.03.94","article-title":"MDA5 Autoantibody-Another Indicator of Clinical Diversity in Dermatomyositis","volume":"5","author":"Sontheimer","year":"2017","journal-title":"Ann Transl Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21728","article-title":"Clinical Manifestations of Dermatomyositis and Clinically Amyopathic Dermatomyositis Patients With Positive Expression of Anti-Melanoma Differentiation-Associated Gene 5 Antibody","volume":"64","author":"Cao","year":"2012","journal-title":"Arthritis Care Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182606f0b","article-title":"A Novel Dermato-Pulmonary Syndrome Associated With MDA-5 Antibodies: Report of 2 Cases and Review of the Literature","volume":"91","author":"Chaisson","year":"2012","journal-title":"Med (United States)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00150-2015","article-title":"An Official European Respiratory Society\/American Thoracic Society Research Statement: Interstitial Pneumonia With Autoimmune Features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/jcm6050051","article-title":"Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia With Autoimmune Features (IPAF)","volume":"6","author":"Jee","year":"2017","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0895","article-title":"Nature and Functions of Autoantibodies","volume":"4","author":"Elkon","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/521369","article-title":"Inflammatory Signalling Associated With Brain Dead Organ Donation: From Brain Injury to Brain Stem Death and Posttransplant Ischaemia Reperfusion Injury","volume":"2013","author":"Watts","year":"2013","journal-title":"J Transpl"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1159\/000499610","article-title":"Organ Preservation Into the 2020s: The Era of Dynamic Intervention","volume":"46","author":"Petrenko","year":"2019","journal-title":"Transfus Med Hemotherapy"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3889","article-title":"The Promise of Organ and Tissue Preservation to Transform Medicine HHS Public Access Author Manuscript","volume":"35","author":"Giwa","year":"2017","journal-title":"Nat Biotechnol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016070756","article-title":"The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications","volume":"28","author":"Cardinal","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000000629","article-title":"Impact of Pretransplant Antibodies on Outcomes After Heart Transplantation","volume":"24","author":"Nunoda","year":"2019","journal-title":"Curr Opin Organ Transpl"},{"key":"B32","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1111\/tri.13487","article-title":"Autoantibodies in Lung Transplantation","volume":"8350","author":"Sureshbabu","year":"2019","journal-title":"Transpl Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2018-0224OC","article-title":"Emphysema-Associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury","volume":"60","author":"Patel","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.31486\/toj.17.0068","article-title":"Non-Human Leukocyte Antigen Antibody-Mediated Lung Transplant Rejection: The Other Anti-a","volume":"18","author":"Vinson","year":"2018","journal-title":"Ochsner J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201210-1865OC","article-title":"Clinical Risk Factors for Primary Graft Dysfunction After Lung Transplantation","volume":"187","author":"Diamond","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejcts.2006.10.024","article-title":"Outcome of Lung Transplanted Patients With Primary Graft Dysfunction","volume":"31","author":"Burton","year":"2007","journal-title":"Eur J Cardio Thoracic Surg"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1348474","article-title":"Primary Graft Dysfunction","volume":"34","author":"Suzuki","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.5152\/TJAR.2015.16443","article-title":"Primary Graft Dysfunction After Lung Transplantation","volume":"43","author":"Altun","year":"2015","journal-title":"Turk Anesteziyoloji ve Reanimasyon Dern Derg"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2013.06.003","article-title":"Pre-Transplant Antibodies to K\u03b11 Tubulin and Collagen-V in Lung Transplantation: Clinical Correlations","volume":"32","author":"Tiriveedhi","year":"2013","journal-title":"J Hear Lung Transpl"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.8.5738","article-title":"Anti-Type V Collagen Humoral Immunity in Lung Transplant Primary Graft Dysfunction","volume":"181","author":"Iwata","year":"2008","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01236.x","article-title":"Anti-Type V Collagen Lymphocytes That Express IL-17 and IL-23 Induce Rejection Pathology in Fresh and Well-Healed Lung Transplants","volume":"6","author":"Yoshida","year":"2006","journal-title":"Am J Transpl"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.4487","article-title":"De Novo Production of K-\u03b11 Tubulin-Specific Antibodies: Role in Chronic Lung Allograft Rejection","volume":"180","author":"Goers","year":"2008","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"101224","DOI":"10.1016\/j.trim.2019.101224","article-title":"Collagen Type-V Is a Danger Signal Associated With Primary Graft Dysfunction in Lung Transplantation","volume":"56","author":"Zaffiri","year":"2019","journal-title":"Transpl Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2010.06.009","article-title":"Antibodies to Self-Antigens Predispose to Primary Lung Allograft Dysfunction and Chronic Rejection","volume":"90","author":"Bharat","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2016-0077OC","article-title":"Lung-Restricted Antibodies Mediate Primary Graft Dysfunction and Prevent Allotolerance After Murine Lung Transplantation","volume":"55","author":"Bharat","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"101271","DOI":"10.1016\/j.trim.2020.101271","article-title":"Pre-Existing Self-Reactive IgA Antibodies Associated With Primary Graft Dysfunction After Lung Transplantation","volume":"59","author":"Kaza","year":"2020","journal-title":"Transpl Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2567.2010.03373.x","article-title":"Integrative Analysis Correlates Donor Transcripts to Recipient Autoantibodies in Primary Graft Dysfunction After Lung Transplantation","volume":"132","author":"Hagedorn","year":"2011","journal-title":"Immunology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2015.151020","article-title":"Antibodies of IgG, IgA and IgM Against Human Bronchial Epithelial Cell in Patients With Chronic Obstructive Pulmonary Disease","volume":"62","author":"Cheng","year":"2016","journal-title":"Clin Lab"},{"key":"B49","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/thoraxjnl-2011-200690","article-title":"Antielastin B-Cell and T-Cell Immunity in Patients With Chronic Obstructive Pulmonary Disease","volume":"67","author":"Rinaldi","year":"2012","journal-title":"Thorax"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nm1583","article-title":"Antielastin Autoimmunity in Tobacco Smoking-Induced Emphysema","volume":"13","author":"Lee","year":"2007","journal-title":"Nat Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.arcmed.2017.01.007","article-title":"Increased Circulating Autoantibodies Levels of IgG, IgA, IgM Against Cytokeratin 18 and Cytokeratin 19 in Chronic Obstructive Pulmonary Disease","volume":"48","author":"Xiong","year":"2017","journal-title":"Arch Med Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2009.12.017","article-title":"Identification and Clinical Association of Anti-Cytokeratin 18 Autoantibody in COPD","volume":"128","author":"Kuo","year":"2010","journal-title":"Immunol Lett"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1038\/cti.2016.57","article-title":"Autoantibodies Against CD80 in Patients With COPD","volume":"5","author":"Luo","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1164\/rccm.201010-1605OC","article-title":"Oxidative Stress-Induced Antibodies to Carbonyl-Modified Protein Correlate With Severity of Chronic Obstructive Pulmonary Disease","volume":"184","author":"Kirkham","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejcdt.2013.11.001","article-title":"Study of Anti Nuclear and Anti Smooth Muscle Antibodies in Patients With Chronic Obstructive Pulmonary Disease","volume":"63","author":"Gouda","year":"2014","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-15-49","article-title":"Persistence of Pulmonary Tertiary Lymphoid Tissues and Anti-Nuclear Antibodies Following Cessation of Cigarette Smoke Exposure","volume":"15","author":"Morissette","year":"2014","journal-title":"Respir Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201001-0029OC","article-title":"Anti-Tissue Antibodies Are Related to Lung Function in Chronic Obstructive Pulmonary Disease","volume":"183","author":"N\u00fa\u00f1ez","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e105066","DOI":"10.1371\/journal.pone.0105066","article-title":"Autoreactivity to Glucose Regulated Protein 78 Links Emphysema and Osteoporosis in Smokers","volume":"9","author":"Bon","year":"2014","journal-title":"PloS One"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep43962","article-title":"Increased Circulating \u03b22-Adrenergic Receptor Autoantibodies Are Associated With Smoking-Related Emphysema","volume":"7","author":"Hu","year":"2017","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150844","article-title":"Rituximab in the Treatment of Jo1 Antibody-Associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response","volume":"43","author":"Bauhammer","year":"2016","journal-title":"J Rheumatol"},{"key":"B61","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/151626","article-title":"Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease in Women With Rheumatoid Arthritis","volume":"2015","author":"Rocha-Mu\u00f1oz","year":"2015","journal-title":"J Immunol Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of Fine Specificity and Repertoire Expansion of Anticitrullinated Peptide Antibodies With Rheumatoid Arthritis Associated Interstitial Lung Disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann Rheumatol Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-018-1545-8","article-title":"Antibodies Against Chemokine Receptors CXCR3 and CXCR4 Predict Progressive Deterioration of Lung Function in Patients With Systemic Sclerosis","volume":"20","author":"Weigold","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201001-0076OC","article-title":"Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis","volume":"183","author":"Taill\u00e9","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2020.100573","article-title":"Angiotensin II Type 1 Receptor Antibodies in Kidney Transplantation: An Evidence-Based Comprehensive Review","volume":"34","author":"Sorohan","year":"2020","journal-title":"Transpl Rev"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2013.06.034","article-title":"Role of Angiotensin II Type 1 Receptor-Activating Antibodies in Solid Organ Transplantation","volume":"74","author":"Reinsmoen","year":"2013","journal-title":"Hum Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trim.2018.10.003","article-title":"Pretransplant Angiotensin II Type 1-Receptor Antibodies Point to an Increase in Renal Graft Sub-Intimal Fibrosis in Living- Donor Kidney Transplant Recipients","volume":"54","author":"Gonz\u00e1lez-Almada","year":"2019","journal-title":"Transpl Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/TP.0b013e3182529bb7","article-title":"Renal Ischemia and Transplantation Predispose to Vascular Constriction Mediated by Angiotensin II Type 1 Receptor-Activating Antibodies","volume":"94","author":"Lukitsch","year":"2012","journal-title":"Transplantation"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II Type 1\u2013Receptor Activating Antibodies in Renal-Allograft Rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.phrs.2017.05.008","article-title":"AT1 Receptor Signaling Pathways in the Cardiovascular System","volume":"125","author":"Kawai","year":"2017","journal-title":"Pharmacol Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4503","article-title":"Angiotensin Receptor Type 1 and Endothelin Receptor Type A on Immune Cells Mediate Migration and the Expression of IL-8 and CCL18 When Stimulated by Autoantibodies From Systemic Sclerosis Patients","volume":"16","author":"G\u00fcnther","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.kint.2019.01.030","article-title":"Non-HLA Agonistic Anti-Angiotensin II Type 1 Receptor Antibodies Induce a Distinctive Phenotype of Antibody-Mediated Rejection in Kidney Transplant Recipients","volume":"96","author":"Lefaucheur","year":"2019","journal-title":"Kidney Int"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12441","article-title":"C4d-Negative Antibody-Mediated Rejection With High Anti-Angiotensin II Type I Receptor Antibodies in Absence of Donor-Specific Antibodies","volume":"20","author":"Fuss","year":"2015","journal-title":"Nephrology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2014.07.007","article-title":"Anti-ETAR and Anti-AT1R Autoantibodies Are Elevated in Patients With Endstage Cystic Fibrosis","volume":"14","author":"Budding","year":"2015","journal-title":"J Cyst Fibros"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181fd97f1","article-title":"Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative Patients","volume":"90","author":"Reinsmoen","year":"2010","journal-title":"Transplantation"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.05.006","article-title":"Anti-Human Leukocyte Antigen Antibodies and Preemptive Antibody-Directed Therapy After Lung Transplantation","volume":"29","author":"Hachem","year":"2010","journal-title":"J Hear Lung Transpl"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.07.018","article-title":"De Novo Donor-Specific HLA Antibodies Are Associated With Early and High-Grade Bronchiolitis Obliterans Syndrome and Death After Lung Transplantation","volume":"33","author":"Morrell","year":"2014","journal-title":"J Hear Lung Transpl"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.07.012","article-title":"De Novo Donor HLA-Specific Antibodies Predict Development of Bronchiolitis Obliterans Syndrome After Lung Transplantation","volume":"33","author":"Safavi","year":"2014","journal-title":"J Hear Lung Transpl"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.09.004","article-title":"Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation","volume":"5","author":"Pearl","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.07.016","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-Fourth Adult Lung And Heart-Lung Transplantation Report\u20142017; Focus Theme: Allograft Ischemic Time","volume":"36","author":"Chambers","year":"2017","journal-title":"J Hear Lung Transpl"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1348467","article-title":"Bronchiolitis Obliterans Syndrome: The Achilles\u2019 Heel of Lung Transplantation","volume":"34","author":"Weigt","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic Lung Allograft Dysfunction: Definition, Diagnostic Criteria, and Approaches to Treatment\u2014A Consensus Report From the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Hear Lung Transpl"},{"key":"B83","article-title":"Chronic Lung Allograft Dysfunction: Definition and Update of Restrictive Allograft Syndrome\u2014A Consensus Report From the Pulmonary Council of the ISHLT","volume":"38","author":"Glanville","year":"2019","journal-title":"J Hear Lung Transpl"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2010.03246.x","article-title":"Chronic Rejection of a Lung Transplant Is Characterized by a Profile of Specific Autoantibodies","volume":"130","author":"Hagedorn","year":"2010","journal-title":"Immunology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.humimm.2020.10.006","article-title":"Self-Reactive Antibodies Associated With Bronchiolitis Obliterans Syndrome Subtype of Chronic Lung Allograft Dysfunction","volume":"82","author":"Kaza","year":"2020","journal-title":"Hum Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2016.04.009","article-title":"Anti-Vimentin Antibodies Present at the Time of Transplantation May Predict Early Development of Interstitial Fibrosis\/Tubular Atrophy","volume":"48","author":"Lopez-Soler","year":"2016","journal-title":"Transpl Proc"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00434","article-title":"Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant Sensitization Against Angiotensin II Type 1 Receptor Is a Risk Factor for Acute Rejection and Graft Loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transpl"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2013.06.006","article-title":"Role of Anti-Vimentin Antibodies in Allograft Rejection","volume":"74","author":"Rose","year":"2013","journal-title":"Hum Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700473","article-title":"Autoimmunity to Vimentin Is Associated With Outcomes of Patients With Idiopathic Pulmonary Fibrosis","volume":"199","author":"Li","year":"2017","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01811.x","article-title":"Detection of Antivimentin Antibody in Sera of Patients With Idiopathic Pulmonary Fibrosis and Non-Specific Interstitial Pneumonia","volume":"128","author":"Yang","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and Function of Immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050390","article-title":"Identification of the Target Self-Antigens in Reperfusion Injury","volume":"203","author":"Zhang","year":"2006","journal-title":"J Exp Med"},{"key":"B94","article-title":"Identification of a Specific Self-Reactive IgM Antibody That Initiates Intestinal Ischemia\/Reperfusion Injury","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102132","article-title":"Pathogenic Natural Antibodies Propagate Cerebral Injury Following Ischemic Stroke in Mice","volume":"188","author":"Elvington","year":"2012","journal-title":"J Immunol"},{"key":"B96","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.0803980","article-title":"Pathogenic Natural Antibodies Recognizing Annexin IV Are Required to Develop Intestinal Ischemia-Reperfusion Injury","volume-title":"J Immunol","author":"Kulik","year":"2009"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.010482","article-title":"Targeting Pathogenic Postischemic Self-Recognition by Natural IgM to Protect Against Posttransplantation Cardiac Reperfusion Injury","volume":"131","author":"Atkinson","year":"2015","journal-title":"Circulation"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2008.06.013","article-title":"Human Natural IgM can Induce Ischemia\/Reperfusion Injury in a Murine Intestinal Model","volume":"45","author":"Zhang","year":"2008","journal-title":"Mol Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00553","article-title":"IgA and Fc\u03b1ri: Pathological Roles and Therapeutic Opportunities","volume":"10","author":"Breedveld","year":"2019","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2976-8","article-title":"The Inflammatory Function of Human IgA","volume":"76","author":"Hansen","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12337","article-title":"The Era of the Immunoglobulin A Fc Receptor Fc\u03b1ri; Its Function and Potential as Target in Disease","volume":"268","author":"Aleyd","year":"2015","journal-title":"Immunol Rev"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15685","article-title":"Molecular Phenotyping of Rejection-Related Changes in Mucosal Biopsies From Lung Transplants","volume":"20","author":"Halloran","year":"2020","journal-title":"Am J Transpl"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200004150-00021","article-title":"Graft-Protective Role of High Pretransplantation IgA-Anti-Fab Autoantibodies: Confirmatory Evidence Obtained in More Than 4000 Kidney Transplants. The Collaborative Transplant Study","volume":"69","author":"Susal","year":"2000","journal-title":"Transplantation"},{"key":"B104","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jtcvs.2018.03.165","article-title":"Low Pretransplant IgA Level Is Associated With Early Post\u2013Lung Transplant Seromucous Infection","volume":"156","author":"Murthy","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2015.02.004","article-title":"The Perfect Storm: HLA Antibodies, Complement, Fc\u03b3rs, and Endothelium in Transplant Rejection","volume":"21","author":"Thomas","year":"2015","journal-title":"Trends Mol Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00433","article-title":"Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation","volume":"7","author":"Valenzuela","year":"2016","journal-title":"Front Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00097","article-title":"A New Classification System for IgG4 Autoantibodies","volume":"9","author":"Koneczny","year":"2018","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/lt.23451","article-title":"Donor-Specific Human Leukocyte Antigen Antibodies of the Immunoglobulin G3 Subclass Are Associated With Chronic Rejection and Graft Loss After Liver Transplantation","volume":"18","author":"Kaneku","year":"2012","journal-title":"Liver Transpl"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12206","article-title":"Donor-Specific HLA Antibodies: Evaluating the Risk for Graft Loss in Renal Transplant Recipients With Isotype Switch From Complement Fixing IgG1\/IgG3 to Noncomplement Fixing IgG2\/IgG4 Anti-HLA Alloantibodies","volume":"27","author":"Arnold","year":"2014","journal-title":"Transpl Int"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31821cdf0d","article-title":"Pretransplant IgG Subclasses of Donor-Specific Human Leukocyte Antigen Antibodies and Development of Antibody-Mediated Rejection","volume":"92","author":"H\u00f6nger","year":"2011","journal-title":"Transplantation"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.21.6632","article-title":"Biological Significance of Carbohydrate Chains on Monoclonal Antibodies","volume":"80","author":"Nose","year":"1983","journal-title":"Proc Natl Acad Sci"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.02.005","article-title":"Fran\u00e7ois & Guilpain, P. Impact of Autoantibody Glycosylation in Autoimmune Diseases","volume":"13","author":"Goulabchand","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in Health and Disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwz065","article-title":"The History of IgG Glycosylation and Where We Are Now","volume":"30","author":"Cobb","year":"2020","journal-title":"Glycobiology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.3390\/ijms21207635","article-title":"Dissecting Total Plasma and Protein-Specific Glycosylation Profiles in Congenital Disorders of Glycosylation","volume":"21","author":"Hipgrave Ederveen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-12495-0","article-title":"Subclass-Specific IgG Glycosylation Is Associated With Markers of Inflammation and Metabolic Health","volume":"7","author":"Plomp","year":"2017","journal-title":"Sci Rep"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0450-1","article-title":"Pro-Inflammatory Pattern of IgG1 Fc Glycosylation in Multiple Sclerosis Cerebrospinal Fluid","volume":"12","author":"Wuhrer","year":"2015","journal-title":"J Neuroinflamm"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M114.039537","article-title":"(IgG) Fab Glycosylation Analysis Using a New Mass Spectrometric High-Throughput Profiling Method Reveals Pregnancy-Associated Changes","volume":"13","author":"Bondt","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"B119","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","article-title":"Immunoglobulin G Glycosylation in Aging and Diseases","volume":"333","author":"Gudelj","year":"2018","journal-title":"Cell Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.12.002","article-title":"Glycans in the Immune System and The Altered Glycan Theory of Autoimmunity: A Critical Review","volume":"57","author":"Maverakis","year":"2015","journal-title":"J Autoimmun"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/316452a0","article-title":"Association of Rheumatoid Arthritis and Primary Osteoarthritis With Changes in the Glycosylation Pattern of Total Serum IgG","volume":"316","author":"Parekh","year":"1985","journal-title":"Nature"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00553","article-title":"Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases","volume":"9","author":"Dekkers","year":"2018","journal-title":"Front Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(02)01250-0","article-title":"Structural Analysis of Human IgG-Fc Glycoforms Reveals a Correlation Between Glycosylation and Structural Integrity","volume":"325","author":"Krapp","year":"2003","journal-title":"J Mol Biol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.bbagen.2005.10.002","article-title":"Glycoform-Dependent Conformational Alteration of the Fc Region of Human Immunoglobulin G1 as Revealed by NMR Spectroscopy","volume":"1760","author":"Yamaguchi","year":"2006","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00877","article-title":"Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities","volume":"8","author":"Dekkers","year":"2017","journal-title":"Front Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1551044","article-title":"Influence of N-Glycosylation on Effector Functions and Thermal Stability of Glycoengineered IgG1 Monoclonal Antibody With Homogeneous Glycoforms","volume":"11","author":"Wada","year":"2019","journal-title":"MAbs"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00646","article-title":"Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity","volume":"8","author":"Peschke","year":"2017","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"102804","DOI":"10.1016\/j.autrev.2021.102804","article-title":"Antibody Glycosylation in Autoimmune Diseases","volume":"20","author":"Zhou","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-018-1695-0","article-title":"N-Glycosylation Patterns of Plasma Proteins and Immunoglobulin G in Chronic Obstructive Pulmonary Disease 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology","volume":"16","author":"Pavi\u0107","year":"2018","journal-title":"J Transl Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3390\/ijms18081731","article-title":"Serum Aberrant N-Glycan Profile as a Marker Associated With Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant","volume":"18","author":"Noro","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.12.027","article-title":"Glycome Patterns of Perfusate in Livers Before Transplantation Associate With Primary Nonfunction","volume":"154","author":"Verhelst","year":"2018","journal-title":"Gastroenterology"},{"key":"B133","article-title":"The Potential of Glycomics as Prognostic Biomarkers in Liver Disease and Liver Transplantation","volume":"82","author":"Verhelst","year":"2019","journal-title":"Acta Gastroenterol Belg"},{"key":"B134","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/j.gastro.2019.08.060","article-title":"Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases","volume":"158","author":"Verhelst","year":"2020","journal-title":"Gastroenterology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.01238","article-title":"Immunoglobulin G Fragment Crystallizable Glycosylation After Hematopoietic Stem Cell Transplantation is Dissimilar to Donor Profiles","volume":"9","author":"de Haan","year":"2018","journal-title":"Front Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.trim.2019.02.006","article-title":"Prevalence of Antibodies to Lung Self-Antigens (K\u03b11 Tubulin and Collagen V) and Donor Specific Antibodies to HLA in Lung Transplant Recipients and Implications for Lung Transplant Outcomes: Single Center Experience","volume":"54","author":"Rao","year":"2019","journal-title":"Transpl Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.711102\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T03:01:16Z","timestamp":1628650876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.711102\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":136,"alternative-id":["10.3389\/fimmu.2021.711102"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.711102","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"article-number":"711102"}}